Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 13 (sodium-dependent citrate transporter), member 5 | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 1 | 0.5 |
Trichomonas vaginalis | Inorganic phosphate transporter, putative | 0.0107 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0107 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0107 | 1 | 1 |
Echinococcus multilocularis | solute carrier family 13 | 0.0107 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0107 | 1 | 1 |
Echinococcus granulosus | solute carrier family 13 | 0.0107 | 1 | 0.5 |
Trichomonas vaginalis | sodium-dependent high-affinity dicarboxylate transporter, putative | 0.0107 | 1 | 1 |
Schistosoma mansoni | sodium/dicarboxylate cotransporter-related | 0.0107 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0107 | 1 | 1 |
Echinococcus granulosus | solute carrier family 13 | 0.0107 | 1 | 0.5 |
Trichomonas vaginalis | Inorganic phosphate transporter, putative | 0.0107 | 1 | 1 |
Echinococcus multilocularis | solute carrier family 13 | 0.0107 | 1 | 0.5 |
Echinococcus granulosus | solute carrier family 13 | 0.0107 | 1 | 0.5 |
Leishmania major | sodium/sulphate symporter, putative | 0.0107 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0107 | 1 | 1 |
Echinococcus multilocularis | solute carrier family 13 | 0.0107 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0107 | 1 | 1 |
Trypanosoma cruzi | Low-affinity phosphate transporter PHO91 | 0.0059 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 6.5 | Inhibition of NaCT in human hepatocytes assessed as [14C]-citrate uptake after 30 mins by scintillation counting method | ChEMBL. | 26734723 |
IC50 (binding) | = 6.9 | Inhibition of NaCT (unknown origin) expressed in HEK293 cells assessed as inhibition of [14C]citrate uptake by microbeta plate reader analysis | ChEMBL. | 26734723 |
IC50 (binding) | = 0.11 uM | Inhibition of NaCT (unknown origin) expressed in HEK293 cells assessed as inhibition of [14C]citrate uptake by microbeta plate reader analysis | ChEMBL. | 26734723 |
IC50 (binding) | = 0.33 uM | Inhibition of NaCT in human hepatocytes assessed as [14C]-citrate uptake after 30 mins by scintillation counting method | ChEMBL. | 26734723 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.